U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07685834) titled 'Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss' on June 29.
Brief Summary: Open-label, randomized double-arm prospective, single-center, self-controlled clinical study.
Study Start Date: Feb. 27
Study Type: INTERVENTIONAL
Condition:
Lax Skin
Intervention:
DEVICE: SUPERB
The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues. Pure Impact is an EMS module. This module is wirelessly connected to and controlled by the SofWave console. It functions indepen...